Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan: implications for the future

GaBI Journal

Volumn 5, Issue 4, 2016, Pages 156-163

  Khan, Babar ^a   Godman, Brian ^b,c   Babar, Ayesha ^a   Hussain, Shahzad ^d   Mahmood, Sidra ^e   Aqeel, Tahir ^a  

^a UNIVERSITY OF LAHORE   (Pakistan)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d NATIONAL INSTITUTE OF HEALTH   (Pakistan)

^e Scotman Pharmaceuticals   (Pakistan)

Author keywords

API (active pharmaceutical ingredient); Drugs Regulatory Authority; Generics; Ibuprofen; Pakistan

Indexed keywords

IBUPROFEN;

ARTICLE; DRUG DETERMINATION; DRUG IMPURITY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG QUALITY; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MATHEMATICAL COMPUTING; MEDICAL DOCUMENTATION; PAKISTAN; PATIENT CARE; PHARMACEUTICAL CARE; QUALITY CONTROL; QUALITY CONTROL PROCEDURES; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 85009802348     PISSN: 20336403     EISSN: 20336772     Source Type: Journal    
DOI: 10.5639/gabij.2016.0504.041     Document Type: Article

References (0)